Exercise and diet in the management of nonalcoholic fatty liver disease

Metabolism: Clinical and Experimental
Suzanne E Mahady, Jacob George

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver condition worldwide, and is projected to become the leading cause for liver transplantation in the United States as early as 2020. The mainstay of treatment remains lifestyle modification with diet and exercise recommendations, as although some pharmacological treatments such as glitazones and Vitamin E have shown benefit, there are concerns regarding long term safety. The evidence base for dietary interventions in NAFLD such as the Mediterranean diet, omega-3 polyunsaturated fatty acids and coffee is mainly derived from observational data with questionable validity. Where trials exist, they have shown benefit for surrogate outcomes such as hepatic steatosis and insulin resistance, but no trials have been conducted with salient clinical outcomes such as reduction in progression to chronic liver disease. Benefit in surrogate outcomes has also been seen for aerobic, anaerobic and combined modality exercise but it remains unclear if one type is superior. Furthermore, a reduction in sedentary time appears equally important. To provide a sound evidence base for lifestyle recommendations to people with NAFLD, longer duration trials of standardized dietary or...Continue Reading

References

Mar 1, 1991·Journal of Hepatology·T AndersenP Christoffersen
Jul 18, 1991·The New England Journal of Medicine·S P HelmrichR S Paffenbarger
Feb 1, 1967·The American Journal of Digestive Diseases·P RozentalH J Zimmerman
Feb 11, 1999·Journal of the American Dietetic Association·D B AllisonJ T Heimbach
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Apr 19, 2002·The New England Journal of Medicine·Paul Angulo
Nov 22, 2002·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A P Simopoulos
Apr 30, 2003·Diabetes Care·Karen A Willey, Maria A Fiatarone Singh
May 23, 2003·The New England Journal of Medicine·Gary D FosterSamuel Klein
Aug 7, 2004·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·G RiccardiA A Rivellese
Oct 7, 2004·Journal of the American College of Nutrition·Thomas L Halton, Frank B Hu
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jeffrey D BrowningHelen H Hobbs
Oct 4, 2005·Clinical Psychology Review·Andrew C ButlerAaron T Beck
Dec 13, 2005·Obesity Research·Riccardo Dalle GraveUNKNOWN QUOVADIS Study Group
Apr 14, 2006·The New England Journal of Medicine·Dariush MozaffarianWalter C Willett
Apr 14, 2006·The New England Journal of Medicine·Steen StenderArne Astrup
Jan 2, 2007·Journal of the American Dietetic Association·Anthony N Fabricatore
Mar 1, 2007·Diabetes Care·Gianluca PerseghinLivio Luzi
Nov 1, 2007·European Journal of Clinical Nutrition·K WijndaeleR M Philippaerts
Feb 13, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Joanne B KrasnoffRaphael B Merriman
Sep 6, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Laura H TetriBrent A Neuschwander-Tetri
Oct 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shira Zelber-SagiRan Oren
Nov 20, 2008·Scandinavian Journal of Gastroenterology·Mattias EkstedtStergios Kechagias
Dec 5, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stephen A HarrisonBrent A Neuschwander-Tetri
Mar 18, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luca MieleAntonio Grieco
Mar 27, 2009·The American Journal of Clinical Nutrition·Emilio Ros
Apr 17, 2009·World Journal of Gastroenterology : WJG·Nimer AssyMaria Grosovski
May 16, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexis St GeorgeJacob George
Jul 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nathan A JohnsonJacob George
Oct 15, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kittichai PromratRena R Wing
Nov 11, 2009·Archives of Internal Medicine·Grant D BrinkworthCarlene J Wilson
Dec 25, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Apurva A ModiJay H Hoofnagle
Jan 21, 2010·Physiological Reviews·Luc Tappy, Kim-Anne Lê
Mar 20, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Manal F AbdelmalekUNKNOWN Nonalcoholic Steatohepatitis Clinical Research Network
Apr 30, 2010·The New England Journal of Medicine·Arun J SanyalUNKNOWN NASH CRN
May 14, 2010·Journal of Hepatology·Noriyuki ObaraTooru Shimosegawa

❮ Previous
Next ❯

Citations

Jan 26, 2016·Metabolism: Clinical and Experimental·Stergios A Polyzos, Christos S Mantzoros
Jun 16, 2016·Metabolism: Clinical and Experimental·Diana BarbKenneth Cusi
May 31, 2016·Metabolism: Clinical and Experimental·Niki KatsikiChristos S Mantzoros
Jun 4, 2016·Journal of Hepatology·Ki-Chul SungChristopher D Byrne
Oct 23, 2016·Journal of Hepatology·Ryuki HashidaTakuji Torimura
Jan 5, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Vlad Ratziu
Jun 1, 2018·Journal of Gastroenterology and Hepatology·Suzanne E Mahady, Leon A Adams
Mar 16, 2019·Expert Review of Gastroenterology & Hepatology·Laura DraijerBart Koot
Dec 19, 2019·Scandinavian Journal of Clinical and Laboratory Investigation·Aki Juhani KäräjämäkiOlavi Ukkola
Nov 20, 2016·Journal of Magnetic Resonance Imaging : JMRI·Ahmed Ba-SsalamahBernard E Van Beers
Jul 6, 2021·Liver Research·Sana RazaRohit A Sinha
Jul 29, 2017·Medicina clínica·Salvador AugustinUNKNOWN en nombre del grupo de trabajo sobre «Hígado graso no alcohólico» de la Societat Catalana de Digestologia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.